Microalbuminuria: a risk factor for vascular and renal complications of hypertension
Kaplan, N.M.
American Journal of Medicine 92(4b): 8s
1992
ISSN/ISBN: 0002-9343 PMID: 1580286 Document Number: 4347
The kidneys are not only involved in the development of hypertension, but they are also often damaged if the disease is not controlled. Microalbuminuria occurs early and is easily diagnosed. However, microalbuminuria is not detected on routine Albustix testing, which has a sensitivity limit of 300 mg/L. Urinary albumin excretion, therefore, should be routinely determined by radioimmunoassay or other techniques so that appropriate therapies can be instituted to prevent nephropathy.
Document emailed within 1 workday
Related Documents
Tepel, M. 2003: A major vascular risk factor: mild impairment of renal function MMW Fortschritte der Medizin 145(15): 51-52Colucciello, M. 2005: Retinal vascular disease in hypertension. Risk factor modification optimizes vision outcomes Postgraduate Medicine 117(6): 33-8 41-2
Kutyrina, I.M.; Rudenko, T.E.; Shvetsov, M.Iu.; Kushnir, V.V. 2006: Risk factors of vascular complications in patients at a predialysis stage of chronic renal failure Terapevticheskii Arkhiv 78(5): 45-50
Nowicki, Mł.; Smoleń, E.; Szklarek, M. 2005: Microalbuminuria--underestimated cardiovascular risk factor Przeglad lekarski 62 Suppl. 2: 15-18
Pérez Fontán, M.; Rodríguez-Carmona, A.; García Falcón, T.; Tresancos, C.; Bouza, P.; Valdés, F. 1998: Peritoneal dialysis is not a risk factor for primary vascular graft thrombosis after renal transplantation Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 18(3): 311-316
De Alvaro, F.; Martínez Castelao, A.; Górriz, J.L. 2005: Importance of early determination of microalbuminuria in global vascular risk and diabetic nephropathy Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 25(Suppl 4): 34-41
Pontremoli, R.; Viazzi, F.; Sofia, A.; Tomolillo, C.; Ruello, N.; Bezante, G.P.; Del Sette, M.; Martinoli, C.; Lotti, R.; Sacchi, G.; Deferrari, G. 1997: Microalbuminuria: a marker of cardiovascular risk and organ damage in essential hypertension Kidney International. Suppl 63: S163-S165
Cho, Y.W.; Cecka, J.M.; Gjertson, D.W.; Terasaki, P.I. 1999: Prolonged hypertension (> 10 years) is a significant risk factor in older cadaver donor renal transplants Transplantation Proceedings 31(1-2): 1283
Casoinic, F.; Sâmpelean, D.; Bădău, C.ăt.ăl.; Prună, L. 2009: Nonalcoholic fatty liver disease--a risk factor for microalbuminuria in type 2 diabetic patients Romanian Journal of Internal Medicine 47(1): 55-59
Zhang, N.; Gong, K.; Yang, X.-Y.; Xin, D.-Q.; Na, Y.-Q. 2006: Expression of hypoxia-inducible factor-1-alpha, hypoxia-inducible factor-2alpha and vascular endothelial growth factor in sporadic clear cell renal cell renal cell carcinoma and their significance in the pathogenesis thereof Zhonghua Yi Xue Za Zhi 86(22): 1526-1529
Acton, R.T.; Bell, D.S.; Collins, J.; Giger, J.N.; Go, R.C.; Harrison, R.; McDonald, R.; Rivers, C.; Roseman, J.M.; Taylor, H.A.; Vanichanan, C. 1997: Genes within and flanking the major histocompatibility region are risk factors for diabetes, insulin resistance, hypertension, and microalbuminuria in African-American women Transplantation proceedings 29(8): 3710-3712
Ploth, D.W. 1990: Influences of angiotensin on renal function in renal vascular hypertension Kidney International. Suppl 30: S97-101
Gorostidi, M.; Marín, R. 2004: Renal vascular disease. Concept and meaning. Epidemiology. Essential arterial hypertension and renal failure. Nephrosclerosis. Ischemic or atherosclerotic nephropathy Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 24 Suppl (6): 73-83; 187-235
Lekston, A.; Chudek, J.; Gasior, M.; Wilczek, K.; Wiecek, A.; Kokot, F.; Szyguła-Jurkiewicz, B.; Wojnicz, R.; Osuch, M.; Poloński, L. 2008: Comparison of early and long-term impact of percutaneous transluminal renal artery angioplasty alone or with brachytherapy on renal function in patients with reno-vascular hypertension Kardiologia Polska 66(10): 1061-1066; Discussion: 1067-1068
Yağci, A.B.; Parildar, M.; Oran, I.; Memiş, A. 2006: Interventional radiological management of vascular complications following renal transplantation Diagnostic and Interventional Radiology 12(4): 206-210
Lechi, C.; Gaino, S.; Zuliani, V.; Tommasoli, R.M.; Faccini, G.; Fasson, R.; Arcaro, G.; Lechi, A.; Minuz, P. 2003: Elevated plasma fibrinogen levels in patients with essential hypertension are related to vascular complications International Angiology: a Journal of the International Union of Angiology 22(1): 72-78
Kunavisarut, P.; Saenpen, N.; Ittipunkul, N.; Patikulsila, D.; Choovuthayakorn, J.; Watanachai, N.; Pathanapitoon, K. 2013: The use of intravitreal anti-vascular endothelial growth factor injection and its complications in Chiang Mai University Hospital Journal of the Medical Association of Thailand 96(11): 1483-1490
Ramachandran, A.; Snehalatha, C.; Satyavani, K.; Latha, E.; Sasikala, R.; Vijay, V. 1999: Prevalence of vascular complications and their risk factors in type 2 diabetes Journal of the Association of Physicians of India 47(12): 1152-1156
Hertig, A. 2010: Anti-vascular endothelial growth factor (VEGF) therapy: a new cause of secondary hypertension La Revue du Praticien 60(5): 644
Walb, D.; Abdelhamid, S. 1975: Renal complications and arterial hypertension in diabetes mellitus Die Medizinische Welt 26(40): 1809-1812